Dr Tsimberidou presents results at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting that show using molecular tests of tumours to select targeted therapy resulted in slower cancer growth and prolonged survival across a diverse set of...
Original Article: Matching mutations in tumours to precision medicine improves survival